⌘K

Login Start Free

Home/Filings/4/0001441844-10-000059

4//SEC Filing

DALTON MARK F 4

Accession 0001441844-10-000059

CIK 0000835887other

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 2:22 PM ET

Size

5.5 KB

Accession

0001441844-10-000059

Insider Transaction Report

Form 4

Period: 2010-07-01

PROGENICS PHARMACEUTICALS INCPGNX

Director

Transactions

Award
Non-Qualified Stock Option (right to buy)
2010-07-01+10,000→ 10,000 total
Exercise: $5.35From: 2010-07-01Exp: 2020-07-01→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]This stock option becomes exercisable immediately, on the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeother

Related Parties

1

filerCIK 0001250267

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 2:22 PM ET
Size: 5.5 KB

View on SEC.gov